Orthocell
Melville
About Orthocell
Orthocell is a Bio-therapeutic company dedicated to improvement of the lives of people suffering from soft tissue injuries by providing innovative approaches to the regeneration of tendon, cartilage and soft tissue injuries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2024)
- Ticker: asx:OCC
- Website: orthocell.com
- Phone: +61 8 9360 2888
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orthocell-178611 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.